FDA clears Stallion digital package
Stallion Technologies is planning its entry into the medical imaging market after receiving 510(k) clearance for a digital image processing package for dynamic x-ray modalities. Stallion began marketing its X-Sight package to medical imaging OEMs and
Stallion Technologies is planning its entry into the medical imaging market after receiving 510(k) clearance for a digital image processing package for dynamic x-ray modalities. Stallion began marketing its X-Sight package to medical imaging OEMs and major distributors after winning Food and Drug Administration clearance in January.
The main feature of X-Sight is its flexibility, according to Marshall Ma, general manager of the Liverpool, NY, company. The package supports a wide range of x-ray systems, including radiography-fluoroscopy, C-arms, angiography suites, and cardiac catheterization labs. X-Sight also is available in configurations that support high-end techniques such as digital subtraction angiography and biplane cardiac cath. In its basic configuration, X-Sight is capable of resolutions of up to 2048 x 2048 in 10 bits, with 12-bit real-time image processing functions. It also supports acquisition rates of up to 120 fps.
X-Sight supports digital acquisition technologies ranging from analog cameras to CCD-based systems, and the company is working on developing an interface to flat-panel digital sensors in development. Stallion is an engineering services firm that has decided to branch out into medical imaging by developing the software used in X-Sight, Ma said.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
